JP2004521140A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004521140A5 JP2004521140A5 JP2002574997A JP2002574997A JP2004521140A5 JP 2004521140 A5 JP2004521140 A5 JP 2004521140A5 JP 2002574997 A JP2002574997 A JP 2002574997A JP 2002574997 A JP2002574997 A JP 2002574997A JP 2004521140 A5 JP2004521140 A5 JP 2004521140A5
- Authority
- JP
- Japan
- Prior art keywords
- administered
- flavopiridol
- days
- taxotere
- medicament according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US27794801P | 2001-03-23 | 2001-03-23 | |
| US30269201P | 2001-07-05 | 2001-07-05 | |
| US33491601P | 2001-12-04 | 2001-12-04 | |
| PCT/EP2002/004083 WO2002076484A2 (en) | 2001-03-23 | 2002-03-22 | Combination of a taxane and a cyclin-dependent kinase inhibitor |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004521140A JP2004521140A (ja) | 2004-07-15 |
| JP2004521140A5 true JP2004521140A5 (OSRAM) | 2005-12-22 |
Family
ID=27402954
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002574997A Pending JP2004521140A (ja) | 2001-03-23 | 2002-03-22 | タキサンおよびサイクリン−依存性キナーゼの組み合わせ |
Country Status (33)
| Country | Link |
|---|---|
| US (2) | US20020182204A1 (OSRAM) |
| EP (1) | EP1372652B1 (OSRAM) |
| JP (1) | JP2004521140A (OSRAM) |
| KR (1) | KR100879712B1 (OSRAM) |
| CN (1) | CN1498107A (OSRAM) |
| AR (1) | AR034222A1 (OSRAM) |
| AT (1) | ATE395917T1 (OSRAM) |
| AU (1) | AU2002312815B2 (OSRAM) |
| BR (1) | BR0208221A (OSRAM) |
| CA (1) | CA2441441C (OSRAM) |
| CY (1) | CY1110449T1 (OSRAM) |
| CZ (1) | CZ301423B6 (OSRAM) |
| DE (1) | DE60226710D1 (OSRAM) |
| DK (1) | DK1372652T3 (OSRAM) |
| EA (1) | EA007815B1 (OSRAM) |
| ES (1) | ES2305253T3 (OSRAM) |
| HR (1) | HRPK20030766B3 (OSRAM) |
| HU (1) | HU229258B1 (OSRAM) |
| IL (2) | IL158058A0 (OSRAM) |
| ME (1) | MEP16408A (OSRAM) |
| MX (1) | MXPA03007743A (OSRAM) |
| NO (1) | NO332441B1 (OSRAM) |
| NZ (1) | NZ527655A (OSRAM) |
| PE (1) | PE20020907A1 (OSRAM) |
| PL (1) | PL206118B1 (OSRAM) |
| PT (1) | PT1372652E (OSRAM) |
| RS (1) | RS50681B (OSRAM) |
| SI (1) | SI1372652T1 (OSRAM) |
| SK (1) | SK287481B6 (OSRAM) |
| TW (1) | TWI355935B (OSRAM) |
| UY (1) | UY27220A1 (OSRAM) |
| WO (1) | WO2002076484A2 (OSRAM) |
| ZA (1) | ZA200307381B (OSRAM) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1487434B1 (en) * | 2002-03-06 | 2007-05-09 | The Medical Research and Education Trust | Botanical extract compositions with anti-cancer activity comprising isoliquiritigenin |
| WO2004035034A2 (en) * | 2002-10-16 | 2004-04-29 | Ilex Products, Inc. | Clofarabine and taxane chemotherapy combination |
| AU2003276467A1 (en) * | 2002-11-06 | 2004-06-07 | Cyclacel Limited | Combination comprising docetaxel and a cdk inhibitor |
| AU2007213791A1 (en) * | 2006-02-10 | 2007-08-16 | Nerviano Medical Sciences S.R.L. | Combinations comprising a CDK inhibitor and a growth factor antibody or anti-mitotic |
| AU2011330733A1 (en) * | 2010-11-19 | 2013-06-06 | Piramal Enterprises Limited | Pharmaceutical combination of paclitaxel and a CDK inhibitor |
| ME03589B (me) | 2011-04-01 | 2020-07-20 | Astrazeneca Ab | Terapeutski tretman |
| PT2785349T (pt) | 2011-11-30 | 2019-12-11 | Astrazeneca Ab | Tratamento combinado de cancro |
| AU2013204533B2 (en) | 2012-04-17 | 2017-02-02 | Astrazeneca Ab | Crystalline forms |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2601675B1 (fr) * | 1986-07-17 | 1988-09-23 | Rhone Poulenc Sante | Derives du taxol, leur preparation et les compositions pharmaceutiques qui les contiennent |
| MX9102128A (es) * | 1990-11-23 | 1992-07-08 | Rhone Poulenc Rorer Sa | Derivados de taxano,procedimiento para su preparacion y composicion farmaceutica que los contiene |
| FR2697752B1 (fr) * | 1992-11-10 | 1995-04-14 | Rhone Poulenc Rorer Sa | Compositions antitumorales contenant des dérivés du taxane. |
| AU2195297A (en) * | 1996-02-20 | 1997-09-02 | Sloan-Kettering Institute For Cancer Research | Combinations of pkc inhibitors and therapeutic agents for treating cancers |
-
2002
- 2002-03-21 UY UY27220A patent/UY27220A1/es not_active Application Discontinuation
- 2002-03-21 US US10/101,947 patent/US20020182204A1/en not_active Abandoned
- 2002-03-22 PT PT02737950T patent/PT1372652E/pt unknown
- 2002-03-22 HR HR20030766A patent/HRPK20030766B3/xx not_active IP Right Cessation
- 2002-03-22 PL PL367702A patent/PL206118B1/pl not_active IP Right Cessation
- 2002-03-22 JP JP2002574997A patent/JP2004521140A/ja active Pending
- 2002-03-22 AU AU2002312815A patent/AU2002312815B2/en not_active Ceased
- 2002-03-22 NZ NZ527655A patent/NZ527655A/xx not_active IP Right Cessation
- 2002-03-22 IL IL15805802A patent/IL158058A0/xx unknown
- 2002-03-22 EP EP02737950A patent/EP1372652B1/en not_active Expired - Lifetime
- 2002-03-22 SK SK1169-2003A patent/SK287481B6/sk not_active IP Right Cessation
- 2002-03-22 CA CA002441441A patent/CA2441441C/en not_active Expired - Fee Related
- 2002-03-22 CZ CZ20032551A patent/CZ301423B6/cs not_active IP Right Cessation
- 2002-03-22 BR BR0208221-7A patent/BR0208221A/pt not_active Application Discontinuation
- 2002-03-22 ES ES02737950T patent/ES2305253T3/es not_active Expired - Lifetime
- 2002-03-22 DE DE60226710T patent/DE60226710D1/de not_active Expired - Lifetime
- 2002-03-22 ME MEP-164/08A patent/MEP16408A/xx unknown
- 2002-03-22 WO PCT/EP2002/004083 patent/WO2002076484A2/en not_active Ceased
- 2002-03-22 CN CNA028070380A patent/CN1498107A/zh active Pending
- 2002-03-22 HU HU0303589A patent/HU229258B1/hu not_active IP Right Cessation
- 2002-03-22 AR ARP020101061A patent/AR034222A1/es unknown
- 2002-03-22 PE PE2002000230A patent/PE20020907A1/es not_active Application Discontinuation
- 2002-03-22 AT AT02737950T patent/ATE395917T1/de active
- 2002-03-22 DK DK02737950T patent/DK1372652T3/da active
- 2002-03-22 MX MXPA03007743A patent/MXPA03007743A/es active IP Right Grant
- 2002-03-22 TW TW091105567A patent/TWI355935B/zh not_active IP Right Cessation
- 2002-03-22 KR KR1020037012338A patent/KR100879712B1/ko not_active Expired - Fee Related
- 2002-03-22 RS YUP-695/03A patent/RS50681B/sr unknown
- 2002-03-22 EA EA200301053A patent/EA007815B1/ru not_active IP Right Cessation
- 2002-03-22 SI SI200230711T patent/SI1372652T1/sl unknown
-
2003
- 2003-09-16 NO NO20034124A patent/NO332441B1/no not_active IP Right Cessation
- 2003-09-22 IL IL158058A patent/IL158058A/en not_active IP Right Cessation
- 2003-09-22 ZA ZA2003/07381A patent/ZA200307381B/en unknown
-
2006
- 2006-01-27 US US11/341,840 patent/US20060128640A1/en not_active Abandoned
-
2008
- 2008-08-11 CY CY20081100843T patent/CY1110449T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2024109585A5 (OSRAM) | ||
| JP2005500357A5 (OSRAM) | ||
| JP2006504723A5 (OSRAM) | ||
| EP1635762A4 (en) | LOW-DOSED PHARMACEUTICAL POWDER FOR INHALATION | |
| CY1115484T1 (el) | Ενωσεις, συνθεσεις και μεθοδοι για την θεραπεια αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων, οπως νοσος alzheimer, διαβητης τυπου 2 και νοσος parkinson | |
| JP2015524444A5 (OSRAM) | ||
| NO20065878L (no) | Terapeutiske forbindelser | |
| NO20065904L (no) | Terapeutiske forbindelser | |
| NO20055880L (no) | Memantin orale doseringsformer | |
| EP1574215A4 (en) | SOLID ARZNEI FOR ORAL ADMINISTRATION | |
| JP2006514116A5 (OSRAM) | ||
| JP2005508963A5 (OSRAM) | ||
| JP2005511619A5 (OSRAM) | ||
| JP2004521140A5 (OSRAM) | ||
| PL1680112T3 (pl) | N-(5-adamantan-1-ylometoksypentylo)deoksynojirimycyna lub dopuszczalna farmaceutycznie sól stosowane w leczeniu oporności na insulinę | |
| JP2006503095A5 (OSRAM) | ||
| JP2002540148A5 (OSRAM) | ||
| JP2005507888A5 (OSRAM) | ||
| JP2002326936A5 (OSRAM) | ||
| JP2005505605A5 (OSRAM) | ||
| RU2004112422A (ru) | Роувастатин в преддеменционных состояниях | |
| NZ527655A (en) | Combination of a taxane (docetaxel) and a cyclin-dependent kinase inhibitor (flavopiridol) | |
| JP2007538066A5 (OSRAM) | ||
| CY1114250T1 (el) | Ακετυλ l-καρνιτινη για την προληψη της επιπονης περιφερικης διαβητικης νευροπαθειας | |
| JP2010519274A5 (OSRAM) |